$106.47
0.23% today
Nasdaq, Jun 30, 10:16 pm CET
ISIN
US09075V1026
Symbol
BNTX
Sector
Industry

BioNTech SE - ADR Target price 2025 - Analyst rating & recommendation

BioNTech SE - ADR Classifications & Recommendation:

Buy
75%
Hold
25%

BioNTech SE - ADR Price Target

Target Price $140.25
Price $106.47
Potential
Number of Estimates 23
23 Analysts have issued a price target BioNTech SE - ADR 2026 . The average BioNTech SE - ADR target price is $140.25. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 28 analysts: 21 Analysts recommend BioNTech SE - ADR to buy, 7 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioNTech SE - ADR stock has an average upside potential 2026 of . Most analysts recommend the BioNTech SE - ADR stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 3.22 2.40
27.96% 25.45%
EBITDA Margin -31.29% -76.65%
209.49% 144.97%
Net Margin -24.18% -62.04%
199.27% 156.54%

24 Analysts have issued a sales forecast BioNTech SE - ADR 2025 . The average BioNTech SE - ADR sales estimate is

$2.4b
Unlock
. This is
25.45% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$3.4b 4.29%
Unlock
, the lowest is
$2.0b 39.41%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $3.2b 27.96%
2025
$2.4b 25.45%
Unlock
2026
$2.7b 10.68%
Unlock
2027
$2.6b 0.93%
Unlock
2028
$3.3b 25.52%
Unlock
2029
$3.8b 14.52%
Unlock
2030
$4.3b 14.14%
Unlock
2031
$5.9b 36.78%
Unlock
2032
$7.0b 17.95%
Unlock

14 Analysts have issued an BioNTech SE - ADR EBITDA forecast 2025. The average BioNTech SE - ADR EBITDA estimate is

$-1.8b
Unlock
. This is
82.64% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-978m 3.03%
Unlock
, the lowest is
$-2.3b 130.06%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-1.0b 178.87%
2025
$-1.8b 82.64%
Unlock
2026
$-2.0b 9.93%
Unlock
2027
$-2.1b 2.17%
Unlock
2028
$605m 129.23%
Unlock
2029
$1.1b 74.66%
Unlock
2030
$1.7b 56.63%
Unlock
2031
$2.3b 41.15%
Unlock
2032
$3.0b 28.10%
Unlock

EBITDA Margin

2024 -31.29% 209.49%
2025
-76.65% 144.97%
Unlock
2026
-76.14% 0.67%
Unlock
2027
-78.51% 3.11%
Unlock
2028
18.28% 123.28%
Unlock
2029
27.88% 52.52%
Unlock
2030
38.27% 37.27%
Unlock
2031
39.49% 3.19%
Unlock
2032
42.89% 8.61%
Unlock

23 BioNTech SE - ADR Analysts have issued a net profit forecast 2025. The average BioNTech SE - ADR net profit estimate is

$-1.5b
Unlock
. This is
91.25% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-682m 12.51%
Unlock
, the lowest is
$-2.2b 178.19%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-780m 171.51%
2025
$-1.5b 91.25%
Unlock
2026
$-1.3b 11.97%
Unlock
2027
$-1.5b 11.92%
Unlock
2028
$-639m 56.48%
Unlock
2029
$-317m 50.49%
Unlock
2030
$44.3m 114.00%
Unlock
2031
$1.5b 3,266.22%
Unlock
2032
$2.2b 44.67%
Unlock

Net Margin

2024 -24.18% 199.27%
2025
-62.04% 156.54%
Unlock
2026
-49.35% 20.45%
Unlock
2027
-55.74% 12.95%
Unlock
2028
-19.33% 65.32%
Unlock
2029
-8.36% 56.75%
Unlock
2030
1.02% 112.20%
Unlock
2031
25.22% 2,372.55%
Unlock
2032
30.93% 22.64%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -3.24 -6.21
172.16% 91.67%
P/E negative
EV/Sales 2.56

23 Analysts have issued a BioNTech SE - ADR forecast for earnings per share. The average BioNTech SE - ADR EPS is

$-6.21
Unlock
. This is
89.33% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-2.84 13.41%
Unlock
, the lowest is
$-9.04 175.61%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-3.24 172.16%
2025
$-6.21 91.67%
Unlock
2026
$-5.47 11.92%
Unlock
2027
$-6.12 11.88%
Unlock
2028
$-2.66 56.54%
Unlock
2029
$-1.32 50.38%
Unlock
2030
$0.18 113.64%
Unlock
2031
$6.22 3,355.56%
Unlock
2032
$8.99 44.53%
Unlock

P/E ratio

Current -32.54 120.76%
2025
-17.17 47.23%
Unlock
2026
-19.51 13.63%
Unlock
2027
-17.43 10.66%
Unlock
2028
-40.05 129.78%
Unlock
2029
-80.89 101.97%
Unlock
2030
577.79 814.29%
Unlock
2031
17.17 97.03%
Unlock
2032
11.87 30.87%
Unlock

Based on analysts' sales estimates for 2025, the BioNTech SE - ADR stock is valued at an EV/Sales of

and an P/S ratio of
10.61
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.90 131.71%
2025
2.56 34.47%
Unlock
2026
2.31 9.65%
Unlock
2027
2.33 0.93%
Unlock
2028
1.86 20.33%
Unlock
2029
1.62 12.68%
Unlock
2030
1.42 12.39%
Unlock
2031
1.04 26.89%
Unlock
2032
0.88 15.22%
Unlock

P/S ratio

Current 7.91 22.26%
2025
10.61 34.13%
Unlock
2026
9.59 9.65%
Unlock
2027
9.68 0.93%
Unlock
2028
7.71 20.33%
Unlock
2029
6.73 12.68%
Unlock
2030
5.90 12.39%
Unlock
2031
4.31 26.89%
Unlock
2032
3.66 15.22%
Unlock

Current BioNTech SE - ADR Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Jun 25 2025
HC Wainwright & Co.
Locked
Locked
Locked Jun 16 2025
HC Wainwright & Co.
Locked
Locked
Locked Jun 05 2025
Truist Securities
Locked
Locked
Locked Jun 03 2025
Goldman Sachs
Locked
Locked
Locked May 29 2025
JP Morgan
Locked
Locked
Locked May 22 2025
HC Wainwright & Co.
Locked
Locked
Locked May 22 2025
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Jun 25 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jun 16 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Jun 05 2025
Locked
Truist Securities:
Locked
Locked
Jun 03 2025
Locked
Goldman Sachs:
Locked
Locked
May 29 2025
Locked
JP Morgan:
Locked
Locked
May 22 2025
Locked
HC Wainwright & Co.:
Locked
Locked
May 22 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today